Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-012367
Filing Date
2023-04-11
Accepted
2023-04-11 08:02:40
Documents
22

Document Format Files

Seq Description Document Type Size
1 DEF 14A kpti-20230410.htm   iXBRL DEF 14A 4078696
2 GRAPHIC img94466677_0.jpg GRAPHIC 33329
3 GRAPHIC img94466677_1.jpg GRAPHIC 8774
4 GRAPHIC img94466677_2.jpg GRAPHIC 33329
5 GRAPHIC img94466677_3.jpg GRAPHIC 509328
6 GRAPHIC img94466677_4.jpg GRAPHIC 473004
7 GRAPHIC img94466677_5.jpg GRAPHIC 495067
8 GRAPHIC img94466677_6.jpg GRAPHIC 69143
9 GRAPHIC img94466677_7.jpg GRAPHIC 64835
  Complete submission text file 0000950170-23-012367.txt   9202823

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20230410.xsd EX-101.SCH 5191
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20230410_lab.xml EX-101.LAB 13018
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20230410_def.xml EX-101.DEF 5993
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20230410_pre.xml EX-101.PRE 7252
16 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20230410_htm.xml XML 441405
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 23812398
SIC: 2834 Pharmaceutical Preparations